Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5'(3')-deoxyribonucleotidase, mitochondrial (NT5M) is an enzyme that localizes to the mitochondrial matrix and plays a crucial role in nucleotide metabolism by dephosphorylating the 5'- and 2'(3')-phosphates of uracil and thymine deoxyribonucleotides. This activity helps regulate the balance of deoxynucleotide triphosphate (dNTP) pools within mitochondria, which is essential for proper DNA replication and repair. Alterations or deletions involving NT5M are implicated in disorders like Smith–Magenis syndrome. Its function is critical for maintaining appropriate nucleotide pools; dysregulation can contribute to genetic diseases involving mtDNA instability or depletion syndromes.
Dephosphorylates uracil and thymine deoxyribonucleotide phosphates
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5'(3')-deoxyribonucleotidase, mitochondrial (NT5M).